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Dementia (from the Latin de mens—from the mind) is not a specific disease itself, but 
rather a group of psychological and behavioral symptoms associated with a variety of 
diseases and conditions that affect the brain (Rabins, Lyketsos, and Steele 1999). 
Generally, dementia is characterized as the loss or impairment of mental abilities. With 
dementia, these cognitive losses (e.g., in reasoning, memory, and thinking) are severe 
enough to interfere with a person's daily life. Additionally, such losses are noticeable in 
a person who is awake and alert—the term dementia does not apply to cognitive 
problems caused by drowsiness, intoxication or simple inattention (American 
Psychiatric Association 1994). 
Although often associated with later life, the symptoms of dementia can affect people 
of any age. Before age sixty-five, however, the incidence of dementia is low—affecting 
one-half to 1 percent of the population (Rabins et al. 1999). As people get older, the 
risk of dementia rises. It is estimated that dementia affects less than 10 percent of the 
sixty-five-and-over population globally (Ikels 1998). The prevalence doubles every 5 
years among people in this age group.  
Despite its prevalence, up to three fourths of dementia goes unrecognized or 
misdiagnosed in its early stages (Sternberg, et al., 2000). Many health care 
professionals mistakenly view the early symptoms of dementia as inevitable 
consequences of ageing or Minimal Cognitive Impairment (MCI). Dementia continues 
to be one of the most common causes of institutionalization, morbidity, and mortality 





Dementia is defined as global impairment of cognitive function that interferes with 
normal activities (APA, 1994). Although impaired memory -both short term and long 
term- are typical of dementia, deficits in other cognitive functions such as abstract 
thinking, judgment, speech, coordination, planning and organization are required to 
make a diagnosis.  
There are many definitions of dementia. The Royal College of Physicians (1982), 
define dementia as the acquired global impairment of higher cortical functions 
including memory, the capacity to solve problems of day-to-day living, the 
performance of learned perceptual and motor skills, the correct use of social skills, all 
aspects of language and communication and the control of emotional reaction, in the 
absence of clouding of consciousness. The condition is often progressive though not 
necessarily irreversible. 
1.1.2 DIAGNOSTIC CRITERIA 
 
 
DSM IV DIAGNOSTIC CRITERIA 
The diagnosis of dementia can be made according to the DSM-IV classification as 
stated below: 
A. The development of multiple cognitive deficits manifested by:- 
¾ Memory impairment (impaired ability to learn new information or to 
recall previously learned information) 
¾ One (or more) of the following cognitive disturbances 
9 aphasia  
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9 apraxia  
9 agnosia  
9 disturbance in executive functioning  
B. The cognitive deficits in criteria A1 and A2 each cause significant impairment in 
social and occupational functioning and represent a significant decline from a previous 
level of functional (APA, 2000). 
INTERNATIONAL CLASSIFICATION OF DISEASES (ICD – 10) DIAGNOSTIC 
CRITERIA: 
Dementia is a syndrome due to disease of the brain, usually of a chronic or progressive 
nature, in which there is disturbance of multiple higher functions, including memory, 
thinking, orientation and comprehension, calculation, learning capacity, language and 
judgment. Consciousness is not clouded. Impairments of cognitive function are 
accompanied and occasionally preceded by deterioration in emotional control, social 
behavior or motivation (WHO, 1992). 
1.1.3 TYPES  
Dementing disorders can be classified in many different ways. These classification 
schemes attempt to group disorders that have particular features in common, such as 
whether they are progressive or what parts of the brain are affected. Examples of types 




I. Cortical Dementia:  
¾ Dementia caused due to damage to the cortex or outer layer is cortical dementia. 
Cortical dementias tend to cause problems with memory, language, thinking and 
social behavior. Some example of cortical dementias are Alzheimer's disease, 
Vascular dementia (also known as multi-infarct dementia), Binswanger's 
disease, Dementia with Lewy bodies (DLB), Alcohol-Induced Persisting 
Dementia, Frontotemporal lobar degenerations (FTLD), including Pick's 
disease, Creutzfeldt-Jakob disease and Dementia pugilistica. 
II. Subcortical Dementia:  
Dementia affecting parts of the brain below cortex is subcortical dementia. This type 
causes changes in emotions and movement in addition to problems with memory. Some 
examples of sub-cortical dementias are Dementia due to Huntington's disease, 
Dementia due to Hypothyroidism, Dementia due to Parkinson's disease, Dementia due 
to Vitamin B1 deficiency, Dementia due to Vitamin B12 deficiency, Dementia due to 
Folate deficiency, Dementia due to Syphilis, Dementia due to Subdural hematoma, 
AIDS dementia complex  
III. Progressive Dementia:  
As the name indicates, the dementia that worsens over a period interfering with 
cognitive abilities is called progressive dementia. 
IV. Primary Dementia:  
Primary dementia does not result from any other disease for example: Alzheimer’s 
disease. 
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V. Secondary Dementia:  
Dementia caused due to a physical disease or injury is called secondary dementia. 
(Karen Ritchie, 2002; Peter, 2003) 
REVERSIBLE DEMENTIAS 
Studies indicate that 10% to 33% of all dementias are potentially reversible (Rabins, et 
al., 1983). The percentage is higher in inpatient and tertiary referral centers. Clearly, 
age of onset is a very important consideration. Treatable causes of dementia occur in 
21% of those under 65 and 5% of those over 65. Unfortunately, even in the potentially 
treatable group of illnesses, response rate is not 100%. Common examples of reversible 
causes of dementia are depression ("pseudo dementia"), dementia due to drug 
intoxication, metabolic-endocrine derangements, Hypothyroidism and normal pressure 
hydrocephalus (Rabin’s, 1983). 
In a prospective study done in India, 18% had reversible cause. However this was a 
study done in a tertiary referral centre (Srikanth, et al., 2005). 
1.1.4 RISK FACTORS FOR DEMENTIA 
The known risk factors for dementia are 
¾ Age 
¾ Genetic factors 
¾ Head injuries (Mehta, 1999). 
¾ History of stroke (Breteler, 1998) 
¾ Vascular disease (Breteler, 1998) 
¾ Alcohol Abuse 
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¾ Low education (Ott et al., 1995) 
¾ Untreated infectious and metabolic disease  
¾ Brain tumor 
¾ Cardiovascular disease (e.g., hypertension, atherosclerosis) 
¾ Kidney failure 
¾ Liver disease and  
¾ Thyroid disease,  
¾ Vitamin deficiencies (B12, folic acid and thiamine). 
 
1.1.5 MANAGEMENT OF DEMENTIA 
 
 
CLINICAL PRACTICE GUIDELINES - SUMMARY OF 
RECOMMENDATIONS (Doody, 2001) 
Dementia is often progressive and symptoms will change over time. Similarly, 
treatment must evolve with time as new issues will emerged as symptoms change. At 
each stage the physician should be alert and help the patient and family anticipate 
future symptoms and care that may be required. 
Psychiatric Aspects of Management 
The core treatment of a patient with dementia is psychiatric care which must be based 
on a close alliance with the family/caregiver. A thorough psychiatric, neurological and 
general medical evaluation to determine the nature of deficits is required for every 
patient. It is critical to identify and treat the general medical conditions that may 
contribute to the dementia and associated behavioural symptoms. 
Ongoing assessment includes periodic monitoring of cognitive and non-cognitive 
psychiatric symptoms and their responses to intervention. It is generally necessary to 
routinely review patients every 3-6 months. More frequent visits may be required for 
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patients with complex or potentially dangerous symptoms or during administration of 
specific therapies. Safety measures need to be constantly evaluated. Educating the 
patient and family about the illness, treatment, sources of care and support, and 
financial and legal issues is important. 
 
NON-PHARMACOLOGICAL INTERVENTIONS 
Non-pharmacological interventions should always be considered along with drug 
options before treatment is started. These include behaviour oriented treatment 
approaches, stimulation oriented treatment approaches and emotion oriented treatment 
approaches. A care plan should be made for each individual and treatment reviewed 
every 3-6 months. 
 
PHARMACOLOGICAL INTERVENTIONS 
Acetylcholinesterase inhibitors show modest efficacy in improving cognition in 
patients with mild to moderate Alzheimer’s disease. Drugs like Donepezil, 
Rivastigmine, Memantine, etc., must only be used after a thorough discussion of their 
potential risks and benefits. There is insufficient evidence at present to recommend the 
routine use of other cognitive enhancers such as vitamin E, selegiline, gingko biloba 
etc. 
Neuroleptic drugs are often required for the management of psychosis, serious 
emotional distress or danger from behavioural disturbances. The choice of drug 
depends on their side-effect profile. Low doses should be prescribed initially with a 
slow and cautious increase, if necessary. Treatment should normally be short term and 
should be reviewed regularly. Awareness of potential side-effects including akathisia 
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and tardive dyskinesia is important; the risk of severe side-effects is greater in Lewy 
body dementia. The routine use of anticholinergics should be avoided. 
 
Marked and persistent depression should be treated with antidepressant medication. 
Severe and persistent anxiety and insomnia may require short-term symptomatic 
treatment.  
 
1.1.6 PROGNOSIS OF DEMENTIA 
The mode of onset and subsequent course of dementia depend on the underlying 
etiology. Dementia may be progressive, static or remitting. The reversibility of 
dementia depends on the underlying pathology, the availability and timely application 
of effective treatment. The prognosis for reversible dementia related to nutritional or 
thyroid problems is usually good once the cause has been identified and treated. The 
prognoses for dementias related to alcoholism or HIV infection depend on the patient's 
age and the severity of the underlying disorder (Wolfson, 2001). Irreversible causes of 
dementia often result in gradual deterioration of the patient's functioning ending in 
death. The natural history of the disease is that of a decline due to progressive damage 
to widespread areas of the brain. The length of time varies. Patients with Alzheimer's 
disease may live from two–20 years with the disease, with an average of seven years. 
Patients with frontal lobe dementia or Pick's disease live on average between five and 
10 years after diagnosis. The course of Creutzfeldt-Jakob disease is much more rapid, 
with patients living between five and 12 months after diagnosis (Wolfson, 2001) 
1.1.7 BURDEN OF DISEASE 
Dementia was estimated to be the 10th leading cause of non-fatal burden in the world in 
1990, accounting for 2.6% of total YLD (Years Lived with a Disability); this is around 
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the same percentage as congenital malformations. In the Version 2 estimates for the 
Global Burden of Disease 2000 study, published in the World Health Report 2002, 
dementia is the 11th leading cause of YLDs at global level, accounting for 2.0% of total 
global YLDs. Despite the difficulties of determining its prevalence and incidence, it is 
clear that dementia causes a substantial burden globally (Mathers, 2000). Dementia 
poses considerable medical, social, and economic concerns as it impacts individuals, 
families and health-care systems throughout the world (National Institute on Aging and 
National Institutes of Health 1999; O'Shea and O'Reilly 2000). The annual costs of 
treating Alzheimer's disease alone, including medical and nursing costs and lost 
productivity have been estimated to be $67 billion (Langa, et al., 2001) to $100 billion 
(Ernst, et al., 1994). 
With the majority of persons with dementia being cared for in the community, it has 
been suggested that the coping mechanisms and resources of families may be severely 
tested (O'Shea and O'Reilly 2000). During the prolonged care period characteristic of 
Alzheimer's disease and other demential conditions, caregivers face the potential for 
social isolation; financial drain; and physical duress (Clyburn et al. 2000). Women are 
particularly vulnerable, as they make up the majority of care providers (Gwyther 2000).  
1.2 PREVALENCE OF DEMENTIA 
1.2.1 INTERNATIONAL DATA 
Prevalence refers to the number of people with dementia in the population at a given 
point in time. There are a large number of prevalence surveys, which have been carried 
out throughout the world. These tend to give slightly different results depending on the 
methods used in the study. However, all studies show a sharp rise in the prevalence of 
dementia with age.  
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In the United States, approximately 5 to 8 percent of people over the age of sixty-five 
suffer from dementia (Tinker 2000). For the oldest old (age seventy-five and over), the 
risk of dementia is much greater. Approximately 18 to 20 percent of those over the age 
of seventy-five have dementia and between 35 to 40 percent of people eighty-five years 
of age or older are affected (Ikels 1998; Rabins et al. 1999; Tinker 2000). 
Thus the prevalence of dementia increases steadily with age, roughly doubling every 5 
years. Studies of community-dwelling elderly have reported dementia in 0.8-1.6% of 
persons 65-74 years old, 7-8% of persons 75-84 years old, and 18-32% of persons over 
85.5. Estimates of the annual incidence of dementia in community-based studies in the 
West are 0.6-1% for ages 65-74, 2-3% for ages 75-84, and 4-8% for ages 85 or older 
(Ritchie, et al., 1992). 
In the famous Rotterdam study 474 cases of dementia were detected, giving an overall 
prevalence of 6.3%. Prevalence ranged from 0.4% (5/1181 subjects) at age 55-59 years 
to 43.2% (19/44) at 95 years and over. Alzheimer's disease was the main sub diagnosis 
(339 cases; 72%); it was also the main cause of the pronounced increase in dementia 
with age. The relative proportion of vascular dementia (76 cases; 16%), Parkinson's 
disease dementia (30; 6%), and other dementias (24; 5%) decreased with age. A 
substantially higher prevalence of dementia was found in subjects with a low level of 
education (Ott, et al., 1995). 
In the Canadian study, 1994, the prevalence of dementia was 8.0% among all 
Canadians aged 65 and over and the female: male ratio was 2:1. The age-standardized 
rate ranged from 2.4%, among those aged 65 to 74 years, to 34.5%, among those aged 
85 and over. The corresponding figures for Alzheimer's disease were 5.1% overall, 
ranging from 1.0% to 26.0%; for vascular dementia it was 1.5% overall, ranging from 
0.6% to 4.8%. 
 18
1.2.2 INCREASE IN PREVALENCE  
Because of the ageing of the world’s population, in the future there will be relatively 
more people in the age groups at most risk for dementia. In the absence of effective 
prevention or treatment, the increase in the numbers of people with dementia will come 
about as a simple consequence of an increase in the size of the population most at risk, 
i.e. of those aged 65 years and over. Between 1990 and 2010, the number of dementia 
cases in the more developed countries is projected to increase from 7.4 million to 10.2 
million (a 37% increase), the elderly population (aged 65+) from 143 million to 185 
million (a 30% increase) and the total population in these countries is projected to 
increase from 1,143 million to 1,213 million (6% increase). Because of the lack of 
prevalence data from the less developed countries, it is difficult to make projections of 
the future number of dementia cases. However, these countries are also ageing rapidly 
and are therefore expected to show an increase in dementia cases. The prevalence rate 
might also conceivably increase if, for example, better care of people with dementia 
meant that they survived longer (Ferri, 2005). 
1.2.3 INDIAN STUDIES  
Investigators have documented prevalence rates for dementia in various community 
surveys in India. In a study conducted in an urban setting in South India to investigate 
the prevalence, psychosocial correlates and risk factors of various dementias, the 
prevalence of dementia was 33.6 per 1000 (95% CI 27.3-40.7). Alzheimer's disease was 
the most common type (54%) followed by vascular dementia (39%), and 7% of cases 
were due to causes such as infection, tumor and trauma. Family history of dementia was 
found to be a risk factor for Alzheimer's disease while a history of hypertension was a 
risk factor for vascular dementia. (Shaji, et al., 2005) 
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In a 3-year epidemiological survey for dementia in an urban community-resident 
population in Mumbai, India, the prevalence rates were as follows: the prevalence rate 
for dementia in those aged 40 years and more was 0.43% and for persons aged 65 and 
above was 2.44%. The overall prevalence rate of dementia was 0.32% and a prevalence 
rate of 1.81% for those aged 65 years and older. The overall prevalence rate for 
Alzheimer's disease (AD) in the population was 0.25%, and 1.5% for those aged 65 
years and above. AD (n = 62; 65%) was the most common cause of dementia followed 
by vascular dementia (n = 23; 22%). There were more women (n = 38) than men (n = 
24) in the AD group (Sachdeva, 2001). 
1.2.4 VARIATION IN RATES 
In various studies the reported prevalence has been lower in India (1.36% to 3.50%) 
compared to the West (5.9% to 9.4%) (Chandra, et al., 1998; Ferri, et al., 2005). True 
differences may be attributed to  
¾ Differing genetic factors 
¾ Environmental factors 
¾ Life expectancy 
¾ Duration with disease and age specific incidence (Prince, et al., 2000). 
Variation in rates may also be as a result of 
¾ Different survey procedures (one stage/two stage)  
¾ Diagnostic criteria used (Henderson,1994) 
¾ Assessment schedules 
¾ Diagnostic instruments used (most instruments not validated in developing 
world) (Jacob, 2007). 
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In a study done to examine the effect of different diagnostic criteria on the prevalence 
of dementia, 10000 subjects aged above 65 years were recruited in a community survey 
using a one-stage procedure. The results showed that the prevalence of dementia was 
different on using different diagnostic criteria. Minor differences in criteria had a 
significant impact on the diagnosis. The assessment was influenced by 
¾ Education (Ott, et al., 1995) 
¾ Level of baseline function 
¾ Lifestyle and demand on the person 
¾ Tolerance of impairment 
¾ Expectation by relatives  
¾ Differences between hospital and community based populations. 
The prevalence according to this study showed wide variation in rates of prevalence 
when different criteria were used. 
Criteria for dementia                                                             Prevalence  
 GMS (using AGECAT)                                                           63.4 %( 60.3-69.6) 
10/66 algorithm (Prince et al., 2003)                                       21.2% (18.7-23.9) 
Education adjusted 10/66 algorithm (Prince et al., 2004)       10.6% (8.8-12.7)  
DSM IV full criteria                                                                 0.8% (0.4-1.6%) 




1.3 ISSUES RELATED TO DIAGNOSIS OF DEMENTIA 
1.3.1 ADVANTAGES OF EARLY DETECTION: 
There are several potential benefits of detecting dementia before patients are severely 
impaired: 
¾ Reversible causes of dementia may be identified and treated.  
¾ Treatments to slow the progression of disease can be instituted.  
¾ Measures can be taken to reduce the morbidity associated with dementia.  
¾ Patients and their family members can anticipate, prepare for problems and plan 
for the future. 
¾ Better control of risk factors for cerebrovascular disease.  
¾ Treatment of associated disorders may improve function in patients with 
dementia.  
¾ Effective interventions can be planned to prevent falls or accidents. 
¾ Decisions about durable power of attorney can be made while the patient is still 
competent to participate.  
1.3.2 PROBLEM OF UNDERRECOGNITION 
Dementia continues to be under-recognized within community practice settings (Bair, 
1998). Dementia is easily recognized in its advanced stages, but numerous studies 
indicate that clinicians often overlook the early signs of dementia. Clinicians fail to 
detect an estimated 21% to 72% of patients with dementia, especially when the disease 
is early in its course. Thus around two thirds of the cases of dementia may remain 
undetected. A population-based study found that the prevalence of undiagnosed 
dementia among individuals aged 65 years and older was 1.8 percent (Sternberg, et al., 
2000). Another population-based study found that about half of the relatives of men 
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with mild dementia failed to recognize a problem with thinking or memory. Among the 
undiagnosed patients the majority had dementia of were mild to moderate severity. 
These low detection rates, the availability of therapy, and the opportunity to elucidate 
patients' preferences for future health planning drives the interest in dementia screening 
programs in primary care. 
1.3.3 BARRIERS TO DISEASE DIAGNOSIS 
The barriers to the diagnosis of dementia include: 
¾ Difficulty in distinguishing early disease from normal aging  
¾ Definitions usually depend upon the impact of the condition on social, 
functional or occupational activities, which can be biased.  
¾ Patients, fearing a label, deliberately minimize their symptoms 
¾ Patients with more advanced dementia may not be aware of their deficits. 
¾ The “homelessness” of clinical management of dementia between various 
medical specialties 
¾ Most psychiatrists do not incorporate a cognitive screen in daily practice.  
¾ Clinicians in the primary care setting are even less inclined to incorporate 
cognitive screening in routine clinical assessments (Knopman, et al., 1998).  
In addition to the above-mentioned reasons, the other factors which lead to under 
recognition of dementia include. 
¾ Patients and their caregivers do not often report cognitive difficulties. 
¾ Cognitive difficulties may be masked by a continued ability to act in a socially 
acceptable manner. 
¾ Physicians fail to recognize early signs. 
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¾ The screening tests currently available are time-consuming 
¾ Some of the most commonly used mental status tests lack the sensitivity and/or 
specificity required for an accurate diagnosis. 
¾ In a small number of cases, co-morbid conditions (especially depression and 
delirium) can make differential diagnosis problematic. 
¾ Lack of training 
Routine screening in primary care practice could, therefore, potentially increase the 
number of patients diagnosed with dementia, and most newly discovered cases would 
have mild to moderate forms of the disease. 
1.3.4 BARRIERS TO SCREENING IN PRACTICE 
Implementation of screening programs would require screening of asymptomatic 
elders, the capacity to conduct an accurate diagnostic assessment, and the resources to 
provide education and management for patients with a confirmed diagnosis. Such 
resources are not available in the typical primary care practice.  
The low predictive value of most screening tests for dementia raises the possibility that 
unselective screening may have adverse effects. Many asymptomatic patients with 
abnormal results on Mini Mental State Examination (MMSE) or other screening tests 
will not have dementia; these patients may be subjected to further tests (e.g., 
neuropsychological testing, blood tests, lumbar puncture, computed tomography [CT]) 
to confirm the diagnosis, rule out other reasons for altered mental status, and assign a 
cause of dementia. Comprehensive follow-up, although posing little risk to patients, 
will be time-consuming and expensive. If clinicians make a diagnosis based on 
screening alone, patients may be incorrectly diagnosed as having a progressive, 
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incurable illness. Nonetheless, in the absence of screening, misdiagnosis of dementia is 
common in outpatient practice.  
1.4 SCREENING FOR DEMENTIA 
1.4.1 ISSUES RELATED TO USE OF SCREENING AND CONFIRMATORY 
TESTS 
It has been highlighted that a screening test would require a high sensitivity, while a 
diagnostic test would require a high specificity (Jacob, 2003). The sensitivity and 
specificity of a diagnostic procedure is constant only when the test and the population 
characteristics remain constant. Moreover the predictive values of tests are dependent 
on the prevalence of the disorder in the population. These predictive values are based 
on the probability of the presence or absence of the phenomenon in question. Thus the 
prevalence of the condition in the population is a major determinant of the predictive 
potential of the tests. Tests used in groups of people with low prevalence of the 
condition to be detected would produce high false positive rates and low positive 
predictive values. 
Confirmatory tests should be used on individuals who have tested positive on the 
screening instrument. This method would artificially increase the prevalence of the 
disorder in the group being tested and would result in more accurate prediction.  
Similarly a screening test employed in high prevalence area may generate high false 
negative rates and low negative predictive values. Optimum test results would be 
obtained when prevalence of the tested condition is around 50%. The use of 
confirmatory tests in patients where the probability for the disease is either too low or 
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too high would demand caution in interpretation as it would increase the likelihood of 
misclassification of subjects as diseased or non-diseased.  
1.4.2 REVIEW OF CURRENTLY AVAILABLE NEUROPSYCHOLOGICAL 
ASSESSMENT TOOLS 
Neuropsychological assessment has retained its key role in the diagnosis of dementia 
despite improvements in neuroimaging techniques, such as magnetic resonance 
imaging (MRI) and single photon emission computerized tomography (SPECT). 
The following are the commonly used screening instruments for cognitive impairment: 
The Mini-Mental State Examination (MMSE) or the Folstein Test 
This is a brief 30 point questionnaire that is used to assess cognition. It is commonly 
used in medicine to screen for dementia. In the time span of about 10 minutes, it 
samples various functions, including arithmentic, memory and orientation. It was 
introduced by Folstein et al in 1975 and is widely used with small modifications. 
Any score over 24 (out of 30) is effectively normal. The normal value is also corrected 
for degree of schooling and age. Low to very low scores correlate closely with the 
presence of dementia. 
A review assessing the validity of the MMSE showed that the reliability and construct 
validity were judged to be satisfactory. Measures of criterion validity showed high 
levels of sensitivity for moderate-to-severe cognitive impairment and lower levels for 
mild degrees of impairment. Content analyses revealed the MMSE was highly verbal, 
and not all items were equally sensitive to cognitive impairment. Items measuring 
language were judged to be relatively easy and lacked utility for identifying mild 
language deficits (Tombaugh, 1992). 
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 In an up to date review the construct validity of the test is considered good. An MMSE 
score of less than or equal to 23 is generally accepted as indicating cognitive 
impairment and was associated with the diagnosis of dementia in at least 79% of cases. 
The major variable that affects the MMSE's sensitivity is the level of cognitive 
impairment. The attainment of high levels of sensitivity increases with increased 
impairment. Specificity was found to be between 80-100%.  
The PHC COG: 
PHC-COG was developed by supplementing informant questionnaires with patient 
questionnaires, the combination of which can increase predictive power. Items were 
derived from four sources: the Mini Mental State Examination, the Barthel Index, the 
Instrumental Activities of Daily Living (IADL), and the Korean Dementia Screening 
Questionnaire (KDSQ). The PHC-cog Patient's Section consists of ten cognitive test 
items. Scoring is based on the total number of incorrect responses, the maximum score 
is 20, and lower scores indicate better functions. (Park et al., 2005) 
The PHC-cog Patient's Section had a sensitivity and specificity of 0.75 and 0.92, 
respectively. The PHC-cog Informants' Section had a sensitivity and specificity of 0.79 
and 0.83, respectively. The total method of administering the PHC-cog had a sensitivity 
and specificity of 0.96 and 0.82, and the two-stage method had a sensitivity and 
specificity of 0.92 and 0.76, respectively. (Park et al., 2005) 
HMSE – Hindi Mental status Examination 
This instrument designed in 1995, was a modified version of the standard MMSE, 
suited for the rural and illiterate population of North India. In this instrument, the 
question about orientation to time was modified as time of the day, day of the week, 
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date, month and season. The orientation to place was modified to assess district, post 
office, village, block and “whose house is this?” The three-word recall of HMSE used 
Hindi version of mango, coin and chair, which was more suitable in this population. 
The WORLD backwards test was modified to saying the days of the week backwards 
and serially reducing bus fare amount in a story recited. The naming test was given 
allowance for local colloquial terms, which were scored right. For repetition, the phrase 
used was “neither this, nor that”.  The visual command test was modified as “Look at 
me and do exactly what I do”. The sentence test was modified to “tell me something 
about your house”. The copying of intersecting pentagons was replaced by a simpler 
diamond with a square (Ganguli, et al., 1995). 
EASI – The Everyday Disability Scale for India 
This instrument was developed to assess the elderly population in rural North India, 
which could be used for screening for dementia in the illiterate population. The test 
items were selected carefully so that it was relevant regardless of sex, socio-economic 
class, caste and culture. The items focus on ADL – 4 related to eating behavior, 4 
related to personal hygiene, 7 related to grooming and 2 related to attention to health 
needs. The reliability and validity of this instrument was tested to be reasonably 
adequate (Ganguli, et al., 1998). 
Abbreviated Mental Test (AMT)  
The Abbreviated Mental Test (AMT) is a brief, 10-item scale used to screen for 
impairments. It was derived by selecting 10 questions with the most discriminatory 
value from the longer Mental Test Score (rated out of 34). It includes components 
requiring intact short and long term memory, attention and orientation. A score of <8 is 
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the usual cut-off suggesting a significant cognitive deficit. It takes approximately 3 min 
to administer in elderly patients. 
There is also a four-question version of the AMT (the AMT4), using the questions age, 
date of birth, place and year only. Scores achieved have been found to correlate 
reasonably well with those from the longer form of the AMT.  The AMT has a lower 
sensitivity and specificity to detect cognitive impairment than the MMSE. The AMT4 
appears to perform even less favorably, although it is particularly quick and easy to 
administer.  
The Clock Drawing Test - CDT 
In this test subjects are asked to draw a clock showing a time of 3 o'clock. Clocks were 
scored using three scoring scales - Shulman, Sunderland, and Wolf-Klein. When 
compared with the MMSE, clock drawing provided additional diagnostic 
discrimination, identifying 7/8 AD patients with MMSE scores = 24 (Brodarty, 1997). 
For the poorly educated subgroup, sensitivity and specificity for detecting dementia by 
clock drawing were 90% and 42% by the Shulman scale, 74% and 44% by the 
Sunderland scale, and 48% and 90% by the Wolf-Klein scale (Seigerschmidt, 2002). 
The 7 Minute Screen – SMS 
The 7MS consists of four brief cognitive tests:  Benton temporal orientation, Enhanced 
cued recall, Clock drawing and Verbal fluency (Meulen, et al., 2004). The overall 
sensitivity of the 7MS for all dementia cases versus controls and cognitively intact 
patients was 91.2%. The sensitivity for Alzheimer’s disease was 92.9%. Sensitivity for 
detecting other dementias was 89.4%. Specificity was 93.5% (Solomon, 1998). 
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The Mini Cog 
The Mini-Cog comprises of 2 subtests - three word recall and clock drawing test. The 
Mini-Cog had higher sensitivity but lower specificity than the MMSE using the 
generally applied MMSE cut off of 24. Specificity and sensitivity were similar when 
the MMSE cut off was raised to 25 (Borson, 2003). 
The RUDAS – The Rowland Universal Dementia Assessment Scale 
The Rowland Universal Dementia Assessment Scale (RUDAS) is a screening test 
developed in a multicultural setting in Australia. It assesses body orientation, praxis, 
drawing, judgment, memory, and language. It has the additional advantage of being 
capable of assessing impairment in executive function. It has a reported sensitivity of 
89% and a specificity of 98% when tested in a multicultural setting in Australia. 
(Rowland et al., 2004) 
 
Short and Sweet Screening Instrument 
The Short and Sweet Screening Instrument (SAS-SI) derives from analysis of tests used 
in the population-based MoVIES study of dementia prevalence and incidence. Used by 
itself, it can be given in 10 minutes. However, the SAS-SI does not contain a memory 
test and therefore does not test a core symptom of dementias in general and of AD in 
particular. The sensitivity and specificity of SASI is 94% and 91%, respectively. 
Short Portable Mental Status Questionnaire 
The Short Portable Mental Status Questionnaire contains a 10-item test aims to detect 
"organic brain syndrome" and is easy to score. It covers short-term recall, long-term 
recall, orientation, current event information and mathematical tasks. The number of 
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errors determines whether the subject is classified as having intact intellectual 
functioning or mild, moderate, or severe intellectual impairment. In a comparison with 
a clinical sample the SPMSQ had a sensitivity of 67% and a specificity of 96%. The 
same evaluation of an institutional sample with a 34% prevalence of dementia showed 
a sensitivity of 26% and a specificity of 98%. 
Cognitive Abilities Screening Instrument 
The CASI samples a broad range of cognitive abilities, and domains of attention and 
concentration, verbal and non-verbal memory, language, visual-spatial functions, 
executive functions and drawing. The CASI incorporates elements of the Mini Mental 
State Exam (MMSE), the Modified Mini-Mental State (3MS), and the Hasegawa 
Dementia Scale for the Aged. Scores of each of these shorter tests can be derived from 
CASI results. The MMSE score derived from the CASI was found to have a correlation 
coefficient of 0.92 compared with the standard MMSE (Graves et al., 1993; McCurry, 
1999). 
The GPCOG 
The General Practitioner Assessment of Cognition (GPCOG) (Brodaty et al., 2002) is 
intended for use in primary practice as a brief screening test for cognitive impairment. 
It has two sections—a patient examination (GPCOG-patient) with a maximum score of 
nine and an informant interview with a maximum score of 6. A GPCOG-patient score 
of 9 indicates no cognitive impairment. If the GPCOG-patient score lies between 5 and 
8 the GPCOG-informant should be administered. A GPCOG-patient score of 4 or lower 
or a GPCOG-informant section score of 3 or lower suggests cognitive impairment. 
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It has been shown to be a valid instrument for detecting dementia with sensitivity and 
specificity of 0.85 and 0.86 respectively in a representative general practice population. 
(Brodaty, et al., 2002) 
Relevance of Informant questionnaire in Dementia Screening:  
A relative, friend or carer who knows the patient well completes an informant 
questionnaire. The advantage of such questionnaires is that they are able to look at more 
than just a snapshot in time, as they ask for an impression of change. For example, the 
history of onset and progression is extremely important when distinguishing between 
delirium and dementia. However, this information would usually be gathered by 
informal interview with a suitable source during standard assessment. Informant 
questionnaires usually give an impression of general decline rather than specific 
domains of cognitive impairment. They are not biased by the patient's baseline 
educational level, but may be influenced by factors regarding the informant's state of 
mind and relationship with the patient. Informant depression or poor relationship with 
the patient tends to cause an over-estimation of cognitive changes, whereas informants 
who do not live with the patient tend to underestimate changes. A number of tools that 
incorporate both patient and informant questioning exist. In addition, some authors have 
proposed methods of adding informant rating scales to standard tools such as the 
MMSE to improve screening accuracy. (Mackinon et al., 1998) 
Informant Questionnaire for Cognitive Decline in the Elderly - IQCODE 
An example is the Informant Questionnaire on Cognitive Decline in the Elderly 
(IQCODE), which asks a person who knows the patient well to answer 26 questions 
based on change in cognitive function over a 10-year period. The IQCODE, developed 
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by Jorm, assesses prior cognitive decline over time, based on ratings of everyday 
cognitive abilities. Informants are asked about the subject’s change in capabilities in 
relation to performance 10 years ago, rating change on a 5-point scale (1 = much better, 
3 = little change, 5 = much worse). The original test had 26 questions, but a shortened 
16-question version has proven just as effective. The short IQCODE takes an average 
of 10 to 12 minutes (range 8 to 15 minutes) to administer. (Jorm, 1996, 2003) 
When compared to DSM-IIIR criteria in elderly people admitted as emergencies to a 
geriatric unit, sensitivities and specificities of 100% and 86% were obtained for the 
IQCODE, compared to 96% and 73% for the AMT (<8). 
1.4.3 PROBLEMS WITH CURRENTLY AVAILABLE SCREENING 
INSTRUMENTS FOR DEMENTIA 
The usual diagnostic standard for dementia consists of detailed assessment of mental 
status and careful investigation to rule out other causes of cognitive impairment. A 
variety of abbreviated instruments have been examined for their ability to screen for 
dementia in the outpatient setting. The most widely studied of these instruments have 
been reviewed above.   
Recent data suggest that level of education and cultural differences have important 
effects on the range of MMSE scores in a given population. Among individuals with 
only 5-8 years of education versus those with college education, the cut-off points that 
identified the lowest 25% on MMSE cut-off may miss significant changes among well-
educated patients (false negative result) and generate more frequent false-positive 
results among persons who are less educated or from different cultures. Thus age, 
education, cultural and socioeconomic background can cause considerable bias in the 
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MMSE scores (Lancou, 2006). The other disadvantage of the MMSE is the difficulty to 
identify MCI and difficulty in recording changes in cases of severe dementia. Moreover 
other mental disorders can also lead to abnormal findings on MMSE testing. The 
presence of purely physical problems can also interfere with the interpretation if not 
properly noted. For example a patient maybe physically unable to hear or read 
instructions properly, or may have motor deficits that affect writing and drawing skills 
(Wind, 2001). 
Shorter screening instruments such as the Short Portable Mental Status Questionnaire 
and the Clock Drawing Test seem to be reasonably sensitive and specific for moderate 
to severe dementia, but they have not been adequately studied as screening tests in 
asymptomatic outpatients. Because they each examine a lesser range of cognitive 
function, they are not likely to be as sensitive as the MMSE or more comprehensive 
tests for detecting early dementia.  
The disadvantages of PHC cog have been education and culture bias. The questions 
based on vaccination, birthday, calculation ability, clothing, construction of the 
intersecting pentagons have an educational bias and a culture-ethnicity bias and cannot 
be used in the developing world for screening. 
RUDAS has been validated in Indian settings against the MMSE (Shaji et al., 2005). 
RUDAS had a similar sensitivity but better specificity than MMSE. Though it was 
culturally fair, it did have an educational bias. The test items in RUDAS, such as 
‘‘crossing the road’’ and ‘‘cube copying’’, especially have an education and culture 
bias. 
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In the GPCOG, the clock drawing component in the patient version is again a pen and 
paper test. This has a culture and educational bias. In the informant version, the 
component about the medication and transport management make the questionnaire 
culture and education biased (Brodaty et al., 2004). 
The Short Portable Mental Status Questionnaire has large effects of literacy on error 
scores and cut-off scores had to be adjusted for education and literacy. The test has 
been criticized for its lack of a learning and memory task. 
In the IQCODE, three items which carry most of the instrument’s power to classify 
cognitive status: learning to use new gadgets, knowing the day and month, and 
handling everyday arithmetic problems have an educational bias.  
In the Clock Drawing Test the clock-drawing ability is affected by education in non-
demented elderly persons. The scoring method of Wolf-Klein is least educationally 
affected and maximizes specificity for detecting dementia but has low sensitivity. 
Educational effects make clock drawing a poor single screening test for dementia in a 
poorly educated population. 
The 7MS, by virtue of its design has been useful only in Alzheimer’s Dementia and not 
in other types of dementia. Its reliability and validity in primary care setting and 
community setting has not been assessed. The Seven Minute Screen also is biased by 
educational background and culture and hence cannot be used for routine community 
screening in developing countries. Moreover if the clinician is not acquainted with the 
7MS, the scoring system can appear difficult (Meulen, et al., 2004). 
The Mini Cog has been not been validated against a gold standard for diagnosis. 
Moreover the Clock drawing component has educational and cultural bias.  
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Increased age and lower education were associated with a lower CASI score, as well as 
an increased spread in score distribution. Gender was also significantly related to total 
CASI, with women having a slightly higher distribution of scores. Like most cognitive 
screening instruments, performance on the CASI in non-demented persons is 
influenced by age and education (Susan, 2001). 
1.5 RATIONALE FOR THE STUDY 
The recognition of dementia by primary care physicians is shown to be poor. Reported 
rates of overlooked dementia are between 35% and more than 90%. Evidence suggests 
that physicians should initiate an early search for reversible causes of dementia, and 
some research suggests that there is a benefit to early intervention with cholinesterase 
inhibitors. For both the patient and the caregiver , the early and timely recognition of 
dementia marks an important transition  from the uncertainty and ambiguity of the early 
cognitive and behavioural change to a phase in which the patient adjusts and learns to 
live with impairment and loss of function. There is indeed a need for timely detection 
and diagnosis that will prevent crises, facilitate adjustment and provide access to 
treatments and support. 
The high prevalence and social costs of dementias in late life and the emergence of 
useful therapies, a growing consensus favors cognitive screening as part of routine 
primary care of the elderly. Routine dementia screening in primary care could achieve 
several useful objectives in addition to dementia detection: it could sensitize primary 
care physicians to the possibility of declining cognition in their older patients, 
accelerate translation of research advances into actual practice, promote development 
of quality standards for dementia care across practice sites and styles, and encourage 
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design of proactive strategies for population-based health care of dementia patients and 
their families. 
The conventional screening instruments have the following drawbacks 
¾ Some are time consuming and need training to use 
¾ Many have language and cultural bias  
¾ Some are dependent on the educational background of the individual.  
¾ Some of these tests require a computer programme to interpret results. 
A brief screening tool with no education, culture or language bias, which has 
also been validated against a standard assessment tool, is still not available for routine 
use in the Tamil population. In this study a new screening instrument was designed so 
as to avoid cultural and educational bias. It was designed to test the main cognitive 
domains using a simple method of scoring and validated against the gold standard for 
















The aim of this study was to design a brief screening instrument for dementia. 
 
SPECIFIC OBJECTIVES 
1. To design a test that is valid and reliable with high sensitivity and specificity. 
2. To design a test that is without significant education, language and culture bias. 
3. To design a test that tests the key cognitive domains affected in dementia. 













3.1 DEVELOPMENT OF INSTRUMENTS 
The first phase of the study involved the development of the screening instrument for 
dementia and its translation into Tamil. 
3.1.1  THE DEVELOPMENT OF THE NEW SCREENING INSTRUMENT-
PHASES OF INSTRUMENT DEVELOPMENT 
The goal of developing the new screening instrument was to identify those subjects in 
the hospital and the community most likely to be currently demented. The instrument 
has been constructed to be reliable, valid, sensitive and specific using simple questions 
that test the key cognitive domains in day-to-day activities. 
Initial selection of potential test items by consensus. 
A panel of psychiatrists developed a series of measures to screen for dementia. Data 
from reviewed literature on screening and diagnostic tests for dementia as well as 
collective clinical and research experience was taken into account. 
Each item and subtest was examined for relevance, adaptability, the conceptual basis 
for the test and the cognitive domain being tapped by the test. Each individual 
screening item was specifically reviewed for their ability to be culture and education 
fair.   
The study and procedures for obtaining informed consent were approved by the 





Pretesting of the test items were carried out on 3 volunteer subjects aged above 65 after 
obtaining informed consent. The objective was to examine the level of difficulty, 
acceptability, comprehensibility and relevance of the potential items and the 
distribution of scores on each subtest and item. 
FIELD STAFF TRAINING AND OPERATIONS MANUAL  
A detailed operations manual with explicit instruction for field staff was prepared and 
modified as the test was modified. Particular attention was paid to listing allowable 
prompts and probes to be used if the subject did not respond or gave a nonspecific or 
irrelevant reply. 
The primary researcher was a qualified psychiatrist. The co-investigators were field 
workers who have extensive experience in the administration of dementia screening 
tests (Jacob et al, 2007).   
3.1.2 TEST DESCRIPTION 
The new screening instrument for dementia comprises of 2 questionnaires-the Patient 
Questionnaire and the Informant Interview. Each questionnaire comprises of 10 
questions each, 2 for each key cognitive domain affected in dementia, based on DSM-
IV (Diagnostic and Statistical Manual 4th Edition) (American Psychiatric Association, 
1994) criteria. The questions are worded in simple terms with a focus on activities of 
daily living. The required time for administration is about 7-10 minutes. The scoring 
was done as 0 or 1 based on the response.  
 
 40
The new screening instrument for dementia-PATIENT QUESTIONNAIRE 
Item description 
Registration: Three objects are given to test memory registration. The Tamil words for 
‘mango, chair, coin,’ were given. A cueing devise was used, as in the Hindi Mental 
State Examination (HMSE) (Ganguli et al, 1995), with the instruction beginning ‘I 
went to Chennai and brought back three things…’The place Chennai was substituted 
for Delhi (used in the HMSE), considering the Tamil population being tested.   
 
Aphasia: This is measured by the ability to comprehend spoken language and to 
formulate oral language. The examiner says ‘Look at my face and do exactly what I do’ 
and then closes his/her eyes for 2 seconds and then opens them. The subject’s response 
is observed. 
Subjects are asked to tell the examiner something about their home using the question,’ 
Say a sentence about your home’. This taps the ability to understand the task of 
generating a complete thought. A point is awarded to any complete sentence offered in 
response. These items have been incorporated from the HMSE (Ganguli et al, 1995). 
 
Apraxia: The ability to execute a voluntary motor movement in response to verbal 
command, to imitate and to handle an object correctly is checked by asking the subject 
to demonstrate simple day-to-day activities. Questions include,’ Show me how you 
light a candle’ and ‘Show me how you comb your hair’. These questions were 
developed for the new scale. 
 
Agnosia: The ability to recognize objects and attach appropriate meaning is checked by 
showing the subject a key and asking him/her to name it. A comb is put into the 
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patient’s hand while his/her eyes are closed and he/she is asked to name it. While this 
item is in other scales, the objects described here were chosen, as they are commonly 
used and considered culturally more appropriate than the wristwatch and pen employed 
in the MMSE (Folstein et al, 1975) and HMSE (Ganguli et al, 1995).  
 
Disturbances in executive functioning: The subject is asked to fold a paper according to 
instructions given. This item is taken from the MMSE (Folstein et al, 1975). A lock and 
key are handed to the patient with instructions to open it. This item from day-to-day life 
was introduced into the new screening instrument. 
 
Recall: The subject is asked to recall the three objects (mango, chair and coin) named 
earlier with a cue,’ Do you remember the three things that I brought from 
Chennai?’This item is from the HMSE (Ganguli et al, 1995). 
 
The new screening instrument for dementia-INFORMANT QUESTIONNAIRE 
Item description 
Memory impairment The relative is asked about any difficulty the patient may have in 
recent memory .The cue of citing an example is used to make the question clearer. The 
examiner asks the question,’ Does he/she regularly forget things that have happened 
recently? For example, does he/she forget that he/she has just eaten and asks again for 
food?’  . This question has been taken form the General Practitioner Assessment of 
Cognition (GPCOG) (Brodaty et al, 2002). A second question regarding trouble 
remembering where the patient has kept his/her belongings was introduced from the 
Short form of the Informant Questionnaire on Cognitive Decline in the Elderly (Short 
IQCODE) (Jorm and Jacomb, 1989). 
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Aphasia: The patient’s ability to comprehend spoken language and to formulate oral 
language is checked by asking the relative questions regarding the patient’s ability to 
find the right words and understand what is said to him/her. This question has been 
taken form the General Practitioner Assessment of Cognition (GPCOG) (Brodaty et al, 
2002). A second question regarding trouble with comprehension was introduced. 
    
Apraxia: The relative is asked about the patient’s ability to dress and use the toilet 
appropriately to assess execution of voluntary motor movements and the ability to 
handle objects correctly. These questions were incorporated into the scale from the 
Everyday Abilities Scale for India (EASI) (Fillenbaum et al 1999).      
                                                                    
Agnosia: The relative is asked if the patient is able to recognize familiar people and 
objects. These questions are routinely used in. These questions are routinely employed 
in neurological interviews (Strub and Black, 1993).  
 
Disturbance in executive functioning: The relative is asked,’ Is he/she able to go to the 
market and purchase things like before’;’ Has he/she ever got lost in the village or 
town’. These questions are used to assess executive functioning using examples form 
day-to day life. Several scales such as the Public Health Centre Cognitive Dysfunction 
Test (PHCcog)(ho et al, 2004) and the GPCOG give a certain activity- such as using 
tools, paying bills- and ask if the patient is able to do it as he used to in the past. In the 
new scale the same theme has been maintained but a more common activity of going to 
the market was substituted in the first question. The second question was taken from 
the Everyday Abilities Scale for India (EASI)(Fillenbaum et al 1999).    
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Decline in functioning: To assess the deterioration in functioning, the relative is asked 
regarding the presence or absence of a worsening of the patient’s problems during the 
previous year. This question was introduced to incorporate information about 
deterioration in functioning, necessary to make a diagnosis of dementia by DSM IV.  
3.1.3 PILOT PHASE 
After the pretest data was examined and appropriates modifications were made to the 
test items, a random sample of subjects above the age of 65 were recruited for a pilot 
study. The researchers administered the new instrument as well as the diagnostic tests 
for dementia to the subjects after obtaining informed consent and basic demographic 
information 
3.1.4 INSTRUMENTS FOR THE DIAGNOSIS OF DEMENTIA 
Dementia was defined as those scoring above a cut point of predicted probability of 
DSM IV Dementia syndrome from the algorithm developed in the 10/66 international 
pilot study, using coefficients from the Geriatric Mental State, Community Screening 
Instrument for Dementia, the modified CERAD10 word learning task and History and 
Aetiology Schedule Dementia Diagnosis and Subtype (Prince et al, 2003). 
The Geriatric Mental State (GMS) (Copeland et al, 1986): This is a standardized 
psychiatric interview and its computerized diagnostic system, AGECAT, has been used 
and updated for over three decades. It has been employed in many countries and in 
diverse settings to diagnose dementia and other psychiatric disorders in the elderly. The 
GMS is considered a flexible and effective case-finding instrument. 
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Community Screening Instrument for Dementia (CSID) (Hall et al, 1993): This test was 
developed as a screening instrument for dementia for use in cross-cultural studies. It 
consists of two components, a cognitive test for non-literate and literate populations 
and an informant interview regarding performance in everyday living. The cognitive 
test covers multiple domains, including orientation to time and space, language, 
memory, praxis, and abstract thinking. It deliberately excludes literacy-dependent 
items. The informant interview assesses a close relative’s perception of a decline in 
memory or intelligence, activities of daily living, and functioning at work and in social 
relations. Three summary scores can be generated from the CSI-D: (a) the cognitive 
score (COGSCORE), an item-weighted total score from the participant’s cognitive test, 
(b) the informant score (RELSCORE), an unweighted total score from the informant 
interview, (c) the discriminant function score (DFSCORE), a weighted score combining 
the COGSCORE and RELSCORE.  
 
Modified CERAD 10-word-list-learning-task (Ganguli et al, 1996) This is the cognitive 
test proposed by the Consortium to Establish a Registry for Alzheimer's Disease 
(CERAD). The Tamil word list consists of the Tamil words for butter, arm, letter, 
queen, ticket, grass, corner, stone, book, and stick, because these were deemed more 
appropriate in the local culture and language. The test yields a total immediate recall 
and a delayed recall score.  
 
History and Etiology Schedule Dementia Diagnosis and Subtype (HAS-DDS) 
(Copeland et al, 2002): It is part of the GMS-AGECAT package and is designed to 
clarify diagnosis into the sub-categories of AGECAT, ICD-10, DSM-IV and to cover 
the MRC's Clinical Information for Studies in Alzheimer's Disease. The HAS interview 
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is designed to be given to the most relevant significant other, if a complete GMS 
interview with the subject is not possible, to supplement the missing report, or to 
validate a report of a questionable subject. 
3.1.5 TRANSLATION OF INSTRUMENT  
The new instrument was translated into Tamil independently by 2 health professionals 
(outside the research team), proficient in both Tamil and English. The Tamil version 
thus obtained was then back translated into English by another 2 bilingual individuals, 
working independently, who were unaware of the original English version. The 
translators then together arrived at a consensus decision on the final Tamil version. 
Care was taken that the translators used language that closely matched the language 
usage of the target group. 
3.2 THE STUDY 
3.2.1 STUDY SETTING AND SITE 
The Christian Medical College is 2234 bedded multi-speciality, tertiary care teaching 
hospital. It has a total of 3700 outpatients a day and runs 76 clinics. 
The Community Health Department of the hospital has been working in Kaniyambadi 
block for the past 50 years. The surveillance system is rigorous and data for the whole 
block is computerized and reviewed monthly by the entire health team. 
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This study was conducted at four different sites- 
Hospital sample: 
i) The out patient clinics of the department of Geriatric Medicine, Christian 
Medical College, Vellore. 
ii) The out patient clinics of the department of Neurology, Christian Medical 
College, Vellore 
iii) The outpatient clinic of the department of Psychiatry, Christian Medical 
College, Vellore 
Community sample: 
The community in the village of Pennathur, Kaniyambadi block. 
3.2.2 DURATION OF THE STUDY 
Participants were recruited between the months of December 2006 and August 2007. 
3.2.3 SUBJECTS 
Neurology and Geriatric Medicine clinics 
Consecutive patients attending these clinics were contacted for possible recruitment 
into the study. Patients who were diagnosed to have dementia clinically using DSM IV 
criteria were chosen and an equal number of patients who did not were included as 
controls.   
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SUBJECTS   
Inclusion criteria  
1. Patients satisfying DSM IV criteria for dementia 
2. Age 65 years and above 
3. Conversant in Tamil  
4. Accompanied by a reliable informant 
Exclusion criteria  
1. Presence of delirium 
2. Patients with hearing impairment 
3. Patients with visual impairment 
4. Patients with wasting and weakness of hands 
CONTROLS 
Inclusion criteria  
1. Patients without dementia 
2. Age 65 years and above 
3. Conversant in Tamil  
4. Accompanied by a reliable informant 
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Exclusion criteria  
1. Presence of delirium 
2. Presence of neurological disorders like Parkinson’s Disease or Cerebrovascular      
accidents  
3. Patients with hearing impairment 
4. Patients with visual impairment 
5. Patients with wasting and weakness of hands 
Psychiatry out patient clinic  
Inclusion criteria  
1. Patients satisfying the ICD 10 criteria for depression 
2. Patients without dementia 
3. Age 65 years and above 
4. Conversant in Tamil  
5. Accompanied by a reliable informant 
Exclusion criteria  
1. Presence of delirium 
2. Presence of neurological disorders like Parkinson’s Disease or Cerebrovascular 
accidents  
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3. Patients with hearing impairment 
4. Patients with visual impairment 
5. Patients with wasting and weakness of hands. 
Community sample 
Inclusion criteria  
1. Age 65 years and above 
2. Conversant in Tamil  
3. Availability of a reliable informant  
Exclusion criteria 
1. Presence of delirium. 
2. Presence of neurological disorders like Parkinson’s Disease or Cerebrovascular      
accidents.  
3. Patients with hearing impairment. 
4. Patients with visual impairment. 






In the hospital, patients and controls were referred to the investigator by their primary 
physicians based on the inclusion and exclusion criteria. Age and suitability for 
inclusion into the study were then confirmed.  
In the community, a list of residents of Pennathur village was obtained from the 
computerized database obtained from the Department of Community Health. With this 
as a guide, a door-to-door survey of the village was done. Eligible participants were 
identified. 
Consent  
The details of the study and the purpose were explained in Tamil to the patient and 
accompanying relative. Written consent was obtained from all participants, prior to 
inclusion in the study. 
Socioeconomic data 
The socio-demographic details for all those recruited were recorded. 
Physical Examination 
A physical examination which included measurement of vital signs and a detailed 
neurological examination was done to assess physical disabilities that could interfere 





Hearing, Vision and Motor assessment 
This was specifically looked into to ensure that the inability to perform the test items 
was not due to physical problems but due to the cognitive impairment.  
Hearing was assessed by asking the patients name in a simple Tamil sentence – “What 
is your name? “. This was asked in a clear tone, normal loudness with no gestures of 
hand. If the subject answered correctly, hearing was assumed to be normal. 
Vision was assessed by asking the patient to identify the direction of the examiner’s 
fingers (‘pointed upwards’ or ‘pointed sideways’). This was done by the examiner 
holding his/her right hand fingers either upwards or sideways at a distance of 18 inches 
from the patients face. If he/she was unable to identify, the test was repeated at 9 inches 
distance. If the subject failed at this distance also he/she was excluded from the study.   
The motor power of the hands was also specifically assessed by the arm drift test. The 
subject was asked to sit with both his hands outstretched in front and with eyes closed. 
Inability to do so or the drift down of one arm was suggestive of weakness and these 
patients were excluded. 
 
Ruling out Delirium 
The reliable informant was asked whether the cognitive impairment was of very recent 
acute onset. An affirmative answer was suggestive of probable delirium and hence such 
patients were excluded from the study. 
 
Preparation of subjects 
 The testing session began with a polite conversation that included collection of the 
socio-demographic data followed by a “DUMMY TEST” which was not scored. The 
dummy test serves to get the subject into the test “set” or “mode”, helping him to 
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comprehend that this is a new type of social situation where specific choices must be 
made, he needs to be alert and precise answers be given. The dummy test was designed 
to appear like a real test but had a high probability of correct responses to provide the 
subject with early success and allay initial anxiety.  
 
Administration of the Questionnaire 
 The administration of the new screening instrument - informant and patient 
questionnaire- was done in privacy. It was ensured that all the patients and the controls 
were administered the questionnaire in the same setting with regard to degree of 
external distracting stimuli. The patient questionnaire was administered first, following 
which the informants were questioned in privacy. The questions were repeated if the 
attention span was inadequate. The scoring was done as 0 or 1 based on the response.  
 
Final Diagnosis using Gold Standard 
The subjects were subsequently administered the battery of confirmative tests by a co-
investigator. These included the Community Screening Instrument for Dementia 
(CSID), Geriatric Mental State (GMS), Modified CERAD 10-word learning test, 
History and Etiology Schedule Dementia Diagnosis and Subtype – HAS – DDS.). Each 
of the diagnostic standards employed was based on the computerized algorithms 
developed by the 10/66 Dementia Research Group (Prince et al., 2003; 2004). 
 
Blinding 
The primary researcher who carried out the screening test for dementia was blind to the 
case/control status of the participants. Data entry was also carried out independent of 
this researcher. The standard diagnostic tests were administered by the co-investigators. 
 53
Referral 
The relatives and caregivers of patients with dementia were briefed about the disease 
and its prognosis, available treatment options and a handout containing information in 
Tamil was also given. In the hospital, the patients were then referred back to the 
treating physicians for further management. Those in the community were referred to 
the hospital. 
 
3.3 STATISTICAL METHODS 
DETERMINATION OF SAMPLE SIZE 
EpiInfo (ver 5.0) (1990) was employed to calculate the sample size for the study. 
The following assumptions were used for the hospital sample: estimated prevalence of 
dementia among the elderly in a hospital setting 25%, estimate of error ± 10%, with a 
95% confidence interval and 80% power. The sample size obtained was 72. 
The following assumptions were used for the community sample: estimated prevalence 
of dementia among the elderly in a community setting 10%, estimate of error ± 6%, 
with a 95% confidence interval and 80% power. The sample size obtained was 96. 
DATA ANALYSIS 
The new screening instrument was validated against the standard of the confirmatory 
test. Sensitivity, specificity, positive and negative predictive values were calculated for 
the screening questions. Receiver operator characteristic (ROC) analysis was used to 
assess the patient section, the informant section and total scores as screening tools for 
DSM IV-defined dementia. The ROC curve was constructed by plotting the true 
positive ratio against the false positive ratio for each possible cutoff point of the test.  
The statistical software SPSS for Windows Release 6.1.3 (SPSS Inc, 1995) was 
employed for the analysis of data. 
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4 .1 HOSPITAL SAMPLE 
4.1.1 SUBJECTS 
A total of 90 subjects were contacted from the hospital clinics -30 from the Geriatric 
clinic, 30 from the neurology clinic and 30 from the psychiatry clinic. All consented to 
participate in the study. An informant was interviewed for each subject included in the 
study.  
4.1.2 SOCIODEMOGRAPHIC PROFILE OF SAMPLE  
Tables 4.1.1 and to 4.1.2 document the sociodemographic profile of the hospital 
sample. 
The mean age of the participants was 71.53 years with a range between 65 and 96 
years. Of the sample, a majority (57.8%) were men. A majority (61.1%) were married 
at the time of the study. Most subjects lived in their own home (84.4%) with their 
family (93.3%). While 24 (26.7%) had never worked, 85 subjects (94.4%) were not 
employed at the time of conducting the study. A majority had an income of their own 
(80%). Many were from a low socio-economic background.17.8% had been unable to 
buy food in the past month due to financial problems and had only two meals a day. 35 
participants (38.9%) had completed primary education, 4 (4.4%) had completed 
secondary education and 6 (6.7%) tertiary education. A majority could read (68.8%) 
and write (62.2%). 43 (47.8%) had diabetes, 40 (44.4%) had hypertension and 9 (10%) 
had a history of cerebrovascular accidents.  
The mean age of the informants accompanying these subjects was 44.03 years with a 
range between 18-82. The majority (55.6%) were female. 33 (36.7%) were the subject’s 
child and 23 were the subject’s spouse (25.6%). A majority (66.7%) were residing with 
the subject. 
 55
Sociodemographic profile of sample 





Sociodemographic characteristic Number % 
Age: Mean (yrs) 
        Standard deviation 











Marital status: Never married 
                       Married 
                       Widowed 









Level of education: None 
Did not complete primary education 
Completed primary education 
Completed secondary education 















Can read: No 





Can write: No 





Housing ownership: Rented 





Type of house: Thatch 
                        Tiled 







Living arrangements: Alone 





Past occupation: None 
                           Unskilled 
                           Semiskilled 









Current occupation: None 
                              Semiskilled 








Table 4.1.1 Hospital sample-Subjects (Continued) 
 
 
Has own income: No 






Family per capita income: Mean (Rs) 
                                         Standard deviation 





Presence of debt: No 





Number of square meals per day: Two 





Had difficulty buying food in  
the past one month: No 







Physical status: Diabetes 
                          Hypertension 
                          Cerebrovascular accidents 












Sociodemographic characteristic Number % 
Age: Mean (yrs) 
        Standard deviation 











Relationship to subject: Spouse 
                                           Child 
                   Son/Daughter-in-law 
                                         Sibling 
                              Other relative 
                                         Friend 















Informant is co-resident: No 





Marital status: Never married 
                       Married 
                       Divorced/separated  









Level of education: None 
Did not complete primary education 
Completed primary education 
Completed secondary education 















Employment: Paid full-time employment 
                       Paid part-time employment 
                 Unemployed (looking for work) 
                     Housewife/ husband (full-time)    
                                                        Retired 













Income source/s: Government pension 
                                 Occupational pension 
                                    Money from family 
                             Income from paid work 
                                      Income from rent 









4.1.3 PREVALENCE OF DEMENTIA IN THE HOSPITAL SAMPLE 
In the hospital sample eighteen (20%) of the ninety subjects interviewed satisfied 
DSM-IV criteria for dementia.  
 
4.1.4 NEW SCREENING INSTRUMENT FOR DEMENTIA 
4.1.4.1 GENERAL DATA  
Patient scores ranged from one to ten with a mean of 6.86 and standard deviation of   
2.68.Informant scores ranged from zero to eleven with a mean of 7.22 and a standard 
deviation of 3.783. 
 
4.1.4.2 VALIDATION 
1) SENSITIVITY AND SPECIFICITY OF THE NEW SCREENING 
INSTRUMENT FOR DEMENTIA 
18 (20 %) individuals met psychiatric case criteria for dementia using the DSM-IV 
diagnostic guidelines. The sensitivity and specificity values of various thresholds of the 
new screening instrument when compared with the standard of DSM IV ‘case-





TABLE 4.1.3 Sensitivity and specificity for different thresholds of the new screening 
instrument for dementia against DSM IV. 
-HOSPITAL SAMPLE 
PATIENT QUESTIONNAIRE  
THRESHOLD SENSITIVITY (%) SPECIFICITY (%) 1-SPECIFICITY 
0/1 0 100 0 
1/2 11.11 94.44 .0556 
2/3 33.33 93.06 .0694 
3/4 50 91.67 .0833 
4/5 72.22 90.28 .0972 
5/6 83.33 88.89 .1111 
6/7 94.44 83.33 .1667 
7/8 100 75 .25 
8/9 100 50 .50 












THRESHOLD SENSITIVITY (%) SPECIFICITY (%) 1-SPECIFICITY 
0/1 28.571 95.83 .0416 
½ 38.89 94.44 .0556 
2/3 55.56 91.67 .0833 
¾ 55.56 90.28 .0972 
4/5 77.78 84.72 .1528 
5/6 77.78 80.55 .1945 
6/7 88.89 75 .25 
7/8 94.44 68.055 .3195 
8/9 100 59.72 .4028 
9/10 100 51.39 .4861 
10/11 100 38.89 .6111 
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2) RECEIVER OPERATOR CHARACTERISTIC CURVE 
Receiver operator characteristic (ROC) curves were constructed (FIGURES 1 and 2).  
The optimal threshold for screening for dementia using the new instrument was found 
to be 6/7 for both the patient and informant questionnaires i.e. all those who scored 6 
and below can be considered a ‘case’. This threshold had a positive predictive value of 
58.62%, a negative predictive value of 98.36%, a false positive rate of 12 % and a false 
negative rate of 1% for the patient questionnaire. The informant questionnaire yielded a 
positive predictive value of 47.06%, a negative predictive value of 96.43%, a false 
positive rate of 18 % and a false negative rate of 2% at this threshold. 
 
RECEIVER OPERATOR CHARATERISTIC CURVES FOR THE NEW SCREENING 
INSTRUMENT FOR DEMENTIA AND DSM IV DIAGNOSIS OF DEMENTIA 



































































4.2 COMMUNITY SAMPLE 
4.2.1 SUBJECTS 
4.2.1.1 THE STUDY SAMPLE 
201 individuals were contacted in the community. Of these 35 did not satisfy inclusion 
criteria, 5 refused consent, 4 had died, 30 had moved out of the village, 10 were 
unavailable despite repeated attempts to contact them and 25 could not be assessed due 
to time constraints. Finally a total of 101 subjects were recruited for the study from the 
community. An informant was interviewed for each subject included in the study. 
 
4.2.1.2 REFUSERS VERSUS CONSENTERS 
The age and sex of those who consented and those who refused to participate in the 
study were compared. Both age and gender were not significantly different between the 




4.2.2`SOCIODEMOGRAPHIC PROFILE OF SAMPLE  
Tables 4.1.3 and 4.1.4 document the sociodemographic profile of the sample. 
The mean age of the participants was 72.49 years with a range between 65 and 85 
years. Of the sample, a majority (59.4%) were women. A majority (56.4%) were 
widowed at the time of the study. Most participants lived in their own home (82.2%) 
with their family (89.1%). While 34 (33.7%) had never worked, 84 subjects (83.2%) 
were not employed at the time of conducting the study. A majority had an income of 
their own (83.2%). Many were from a low socio-economic background.24.8% had been 
unable to buy food in the past month due to financial problems and 31.7% had only two 
meals a day.21.8% had financial debts. A majority (53.5%) had had no formal 
education and could not read (54.5%) or write (57.4%). 19 (18 %) had diabetes, 26 (25 
%) had hypertension and 2 (2%) had a history of cerebrovascular accidents.  
The mean age of the informants accompanying these subjects was 42.98 years with a 
range between 19-83. The majority (82.2%) were female .25 (24.8%) were the subject’s 
spouse, 23 were the subject’s child (22.8 %) and 25 (24.8%0 were a son or daughter-in- 
law .A majority 77 (76.2%) were residing with the subject. 
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Sociodemographic characteristic       Number 
% 
Age: Mean (yrs) 
        Standard deviation 











Marital status: Never married 
                       Married 
                       Widowed 









Level of education: None 
Did not complete primary education 
Completed primary education 










Can read: No 





Can write: No 





Housing ownership: Squatting 
                                Rented 







Type of house: Thatch 
                        Tiled 







Living arrangements: Alone 





Past occupation: None 
                           Unskilled 
                           Semiskilled 









Current occupation: None 
                               Unskilled 















Has own income: No 






Family per capita income: Mean (Rs) 
                                         Standard deviation 





Presence of debt: No 





Number of square meals per day: Two 





Had difficulty buying food in  
the past one month: No 







Physical status: Diabetes 
                               Hypertension 
                               Cerebrovascular accidents 












Sociodemographic characteristic       Number 
% 
Age: Mean (yrs) 
        Standard deviation 











Relationship to subject: Spouse 
                                           Child 
                   Son/Daughter-in-law 
                                         Sibling 
                              Other relative 
                                         Friend 















Informant is co resident: No 





Marital status: Never married 
                       Married 







Level of education: None 
Did not complete primary education 
Completed primary education 
Completed secondary education 













Employment: Paid full-time employment 
                       Paid part-time employment 
                 Unemployed (looking for work) 
                                                        Student 
                  Housewife/ husband (full-time) 













Income source/s: Government pension 
                        Occupational pension 
                           Money from family 
                    Income from paid work 
                                                 Other 









4.2.3  PREVALENCE OF DEMENTIA IN THE COMMUNITY SAMPLE 
In the community, three (2.97%) of one hundred and one subjects interviewed satisfied 
DSM-IV criteria for dementia.  
 
4.2.4  NEW SCREENING INSTRUMENT FOR DEMENTIA 
4.2.4.1 GENERAL DATA 
Patient scores ranged from three to ten with a mean of 8.09 and standard deviation of   
1.13.Informant scores ranged from five to eleven with a mean of 9.71 and standard 
deviation of 1.63. 
 
4.2.4.2 VALIDATION 
1) SENSITIVITY AND SPECIFICITY OF THE NEW SCREENING 
INSTRUMENT 
3 (2.97%) individuals met psychiatric case criteria for dementia using the DSM-IV 
diagnostic guidelines. The sensitivity and specificity values of various thresholds of the 
new screening instrument when compared with the standard of DSM IV ‘case-
noncaseness’ is shown in Table  4.2.3. 
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TABLE 4.2.3 Sensitivity and specificity for different thresholds of the new screening 
instrument for dementia against DSM IV 
COMMUNITY SAMPLE 
PATIENT QUESTIONNAIRE 
THRESHOLD SENSITIVITY (%) SPECIFICITY (%) 1-SPECIFICITY 
0/1 0 1 0 
½ 0 1 0 
2/3 0 1 0 
¾ 0 98.98 .0102 
4/5 33.33 98.98 .0102 
5/6 33.33 97.96 .0204 
6/7 66.67 94.90 .0510 
7/8 66.67 78.57 .2142 
8/9 100 44.90 .5510 
9/10 100 1.02 .9897 
 
INFORMANT QUESTIONNAIRE 
THRESHOLD SENSITIVITY (%) SPECIFICITY (%) 1-SPECIFICITY 
0/1 0 100 0 
½ 0 100 0 
2/3 0 100 0 
¾ 0 100 0 
4/5 0 100 0 
5/6 0 97.96 .0204 
6/7 33.33 94.897 .0510 
7/8 66.67 86.73 .1327 
8/9 100 80.61 .1939 
9/10 100 74.49 .2551 
10/11 100 44.897 .5510 
 
2) RECEIVER OPERATOR CHARACTERISTIC CURVE 
Receiver operator characteristic (ROC) curves were constructed (FIGURES 3 and 4).  
The optimal threshold for screening for dementia using the patient questionnaire of the 
new instrument was 6/7 i.e. all those who scored 6 and below can be considered a 
‘case’. This threshold had a positive predictive value of 28.57%, a negative predictive 
value of 98.94 %, a false positive rate of 5 % and a false negative rate of 1%  .The 
optimal threshold for screening for dementia using the new instrument’s informant 
questionnaire was 8/9 i.e. all those who scored 8 and below can be considered a ‘case’. 
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This threshold had a positive predictive value of 13.64 %, a negative predictive value of 
100 %, a false positive rate of 19 % and a false negative rate of 0%. 
 
RECEIVER OPERATOR CHARATERISTIC CURVES FOR THE NEW SCREENING 














































































4 .3 TOTAL SAMPLE (COMBINED HOSPITAL and COMMUNITY DATA) 
 
4.3.1 THE STUDY SAMPLE 
A total of 191 subjects were included in the study .An informant was interviewed for 
each subject included in the study.  
4.3.2  PREVALENCE OF DEMENTIA IN THE ENTIRE SAMPLE 
Twenty-one subjects from the entire sample (10.99%) met psychiatric case criteria for 
dementia using the DSM-IV diagnostic guidelines. Of these eighteen (85.7%) were 






4.3.3 NEW SCREENING INSTRUMENT FOR DEMENTIA 
4.3.3.1 GENERAL DATA 
Patient scores ranged from one to ten with a mean of 7.51 and standard deviation of   
2.09.Informant scores ranged from zero to eleven with a mean of 8.54 and standard 
deviation of 3.106. 
4.3.3.2 VALIDATION 
1) SENSITIVITY AND SPECIFICITY OF THE NEW SCREENING 
INSTRUMENT 
The sensitivity and specificity values of various thresholds of the new screening 
instrument when compared with the standard of DSM IV ‘case-noncaseness’ is shown 
in Tables 4.3.1 and 4.3.2. 
TABLE 4.3.1 Sensitivity and specificity for different thresholds of the new screening 




THRESHOLD SENSITIVITY (%) SPECIFICITY (%) 1-SPECIFICITY 
0/1 0 1 0 
½ 9.52 97.65 .0235 
2/3 28.6 97.1 .029 
¾ 42.9 95.9 .041 
4/5 66.67 95.3 .047 
5/6 76.2 94.1 .059 
6/7 90.5 90.0 .10 
7/8 95.2 77.1 .229 
8/9 100 47.1 .529 







THRESHOLD SENSITIVITY (%) SPECIFICITY (%) 1-SPECIFICITY 
0/1 19.05 98.24 .0176 
½ 33.33 97.65 .0235 
2/3 47.62 96.47 .0353 
¾ 47.62 95.88 .0412 
4/5 66.67 93.53 .0647 
5/6 66.67 90.59 .0941 
6/7 80.95 86.47 .1353 
7/8 90.48 78.82 .2117 
8/9 100 71.76 .2824 
9/10 100 64.71 .3529 
10/11 100 42.35 .5765 
 
In the entire sample the optimal threshold for screening for dementia using the patient 
questionnaire of the new instrument was 7/8 i.e. all those who scored 7 and below can 
be considered a ‘case’. This threshold had a positive predictive value of 33.89%, a 
negative predictive value of 99.24%, a false positive rate of 39 % and a false negative 
rate of 1%  .The optimal threshold for screening for dementia using the new 
instrument’s informant interview was 6/7 i.e. all those who scored 6 and below can be 
considered a ‘case’. This threshold had a positive predictive value of 42.5%, a negative 
predictive value of 97.35%, a false positive rate of 23 % and a false negative rate of 
4%.  . 
 
2) RECEIVER OPERATOR CHARACTERISTIC CURVE 
Receiver operator characteristic (ROC) curves were constructed (FIGURES 5 and 6). 
In the entire sample the optimal threshold for screening for dementia using the patient 
questionnaire of the new instrument was7/8 i.e. all those who scored 7 and below can 
be considered a ‘case’. This threshold had a positive predictive value of 33.89%, a 
negative predictive value of 99.24%, a false positive rate of 39 % and a false negative 
rate of 1%  .The optimal threshold for screening for dementia using the informant 
interview was 6/7 i.e. all those who scored 6 and below can be considered a ‘case’. This 
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threshold had a positive predictive value of 42.5%, a negative predictive value of 
97.35%, a false positive rate of 23 % and a false negative rate of 4%.  . 
 
RECEIVER OPERATOR CHARATERISTIC CURVES FOR THE NEW SCREENING 














































































In the hospital a total of 90 individuals were contacted and recruited into the study 
after consent. The majority were male (57.8%), married (61.1%), could read (67.8%) 
and write (62.2%), lived with their family (93.3%) and were currently unemployed 
(94.4%). The mean age was 71.53 years (SD 6.691). 
18 subjects (21.11 %) satisfied DSM IV criteria for dementia. The optimum threshold 
for screening, obtained using a receiver operator characteristic curve, was 6/7 .For the 
patient questionnaire the positive and negative predictive values at this threshold were 
58.62% and 98.36% while sensitivity and specificity were 94.44 and 83.33 
respectively. For the informant questionnaire the positive and negative predictive 
values at this threshold were 47.06% and 96.43% while sensitivity and specificity were 
88.89% and 75% respectively. 
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In the community a total of 101 individuals were contacted and recruited into the 
study after consent. The majority were female (59.4%), widowed (56.4%), could not 
read (54.5%) and write (57.4%), lived with their family (89.1%) and were currently 
unemployed (83.2%). The mean age was 72.49 years (SD 5.545). 
3 subjects (2.97 %) satisfied DSM IV criteria for dementia. The optimum threshold for 
screening using with the patient questionnaire obtained using a receiver operator 
characteristic curve, was 6/7 .The positive and negative predictive values at this 
threshold were 28.57% and 98.94% while sensitivity and specificity were 66.67% and 
94.90% respectively. The optimum threshold for screening using with the informant 
questionnaire obtained using a receiver operator characteristic curve, was 8/9 .The 
positive and negative predictive values at this threshold were 13.64% and 100% while 
sensitivity and specificity were 100% and 80.61% respectively. 
 
In the entire sample the optimal threshold for screening for dementia using the patient 
questionnaire of the screening instrument was 7/8. This threshold had a positive 
predictive value of 33.89%, a negative predictive value of 99.24%, a sensitivity of 
95.2% and specificity of 77.1%. The optimal threshold for screening for dementia using 
the informant questionnaire was 6/7. This threshold had a positive predictive value of 







Screening for dementia is an important component of clinical practice Routine 
screening for dementia increases the pick up rates and promotes better standards of 
dementia care in the health care system. 
There are several screening instrument that are currently available. However, there are 
different problems with the different tests-these include the length of the assessment, 
bias related to the age, language, education and ethnicity of the subject and the 
requirement of special training to use or a computer programme to interpret. This study 
attempted to create a brief screening tool for dementia, free of the above problems and 
validated against standard diagnostic criteria, for routine use in clinical practice. 
5.2 METHODOLOGICAL CONSIDERATIONS 
Instruments The DSM IV was chosen as the diagnostic standard against which the 
new screening instrument was validated, as this is the criterion that is used in routine 
clinical practice. The items of the new instrument were chosen after careful 
examination for relevance, adaptability, the conceptual basis for the test and the 
cognitive domain being tapped by the test. Each individual screening item was 
specifically reviewed for their ability to be culture and education fair.  
Translation During the translation of the screening instrument to Tamil, care was 
taken to use language as spoken by the local people to ensure that it would be 
appropriate to the study population. 
Sample size This was sufficiently large to draw valid conclusions from the study. 
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Subjects Subjects were chosen from within the hospital, who had passed through a 
referral system, as well as from individuals residing in the community. 
Setting The screening and interview procedures in the hospital were carried out in busy 
outpatient settings with constraints of time and privacy. While this could influence the 
results of the study, the instrument was designed for use in such situations. The 
community interviews took pace at the individual’s residence. 
Procedure Since a large number of the subjects and their informants were not literate, 
the instruments were not self-administered, but were instead read out to them using the 
recommended procedure. 
5.3 PREVALENCE OF DEMENTIA IN THE STUDY POPULATION 
Dementia in the hospital sample studied was 20 %. Many from this group were brought 
to the hospital by their relatives with symptoms and were then referred to the researcher 
by their primary physicians. This would explain the relatively high rate obtained. 
In the community the rate of dementia was 2.97%. Reported prevalence from Indian 
community studies have ranged from 0.8% (Jacob et al, 2007) to 3.50% (Ferri et al, 
2005). 
5.4 VALIDITY OF THE NEW SCREENING INSTRUMENT 
Screening tests require a high sensitivity .The Patient and Informant Questionnaires of 
the new screening instrument were found to have a high sensitivity and specificity in 
the hospital population being screened for dementia. The threshold of 6/7 appears to be 
efficient for screening in this population. 
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In the community sample, the instrument had a poor sensitivity though the specificity 
was high. The poor positive predictive value of the test is related to the low prevalence 
of dementia in the community. Thresholds of 6/7 for the patient questionnaire and 8/9 
for the informant questionnaire were the most efficient for this population.  
5.5 SIGNIFICANCE 
The high sensitivity and specificity of the new screening instrument for dementia 
suggest that it is a valid instrument for screening for dementia in a clinical population. 
5.6 RECOMMENDATIONS FOR FUTURE DIRECTIONS FOR RESEARCH 
Differences in information, interview schedules, diagnostic criteria and settings 
contribute to variation in identification of people with dementia. The new screening 
instrument can be used for the screening for dementia in clinical settings. Applying the 
instrument to people in the community who are reported by their relatives to have 
symptoms of dementia would artificially raise the prevalence of dementia in the group 
being tested and would result in more accurate prediction. This is a preliminary study 
that needs to be further validated. 
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SUMMARY AND CONCLUSIONS 
1. A brief screening instrument for dementia was developed. 
2. The new instrument was validated for use in clinical and community populations 
against the standard diagnostic criteria of the DSM IV. The instrument was found to 
have a high sensitivity and specificity for the patient (94.44% and 83.33%) and 
informant (88.89% and 75%) questionnaires and is an efficient tool for screening for 
dementia in a clinical setting with a threshold of 6/7. 
In the community, the patient questionnaire had a sensitivity and specificity of 66.67% 
and 94.90% respectively at the threshold of 6/7 for the patient questionnaire, and a 
sensitivity and specificity of 100% and 80.61% respectively at a threshold of 8/9 for the 
informant questionnaire. 
3. The high sensitivity and specificity of the new screening instrument for the 
identification of dementia and its ease of administration make it a valuable tool for 
screening in clinical settings. 
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1) I WENT TO CHENNAI AND BROUGHT BACK 3 THINGS: THEY ARE 
A MANGO, A CHAIR AND A COIN.  CAN YOU TELL ME THE 
THREE THINGS I BROUGHT? 
Remember these three things that I got from Chennai. I will ask you to repeat it 
after sometime                                                                        
2) LOOK AT MY FACE AND DO EXACTLY WHAT I DO.  (Close your eyes 
for 2 seconds and then open them) 
3) SAY A SENTENCE ABOUT YOUR HOME. 
4) SHOW ME HOW YOU LIGHT A CANDLE. 
5) SHOW ME HOW YOU COMB YOUR HAIR. 
6) WHAT IS THIS? (Show a key). 
7) CLOSE YOUR EYES AND TELL ME WHAT IS IN YOUR HAND. (Put a 
comb into the patient’s hand). 
8) TAKE THIS PAPER WITH YOUR RIGHT HAND, FOLD IT INTO 2 
AND PUT IT DOWN ON THE LEFT SIDE OF THE TABLE. 
9) CAN YOU OPEN THIS LOCK? 
10)  DO YOU REMEMBER WHAT THE 3 THINGS THAT I BROUGHT 




1) DOES HE/SHE REGULARLY FORGET THINGS YHAT HAVE HAPPENED 
RECENTLY?  
For example, does he/she forget that he/she has just eaten and asks for food again?                                 
(i) YES       (ii) NO   
2) DOES HE/SHE HAVE TROUBLE REMBERING WHERE HE/SHE HAS 
KEPT HER BELONGINGS?  
For example does he/she regularly forget where he/she has left the money? 
                                                                   (i) YES      (ii) NO 
3) DOES HE OR SHE REGULARLY HAVE DIFFICULTY FINDING THE 
RIGHT WORDS OR DOES HE OFTEN USE THE WRONG WORDS IN 
CONVERSATION? 
                                                                   (i) YES      (ii) NO 
4) DOES HE/SHE REGULARLY HAVE DIFFICULTY UNDERSTANDING 
WHAT IS SAID TO HIM/HER? 
Foe example is he able to follow instructions or? 
                                                                    (i) YES      (ii) NO                                                                  
5) DOES HE/SHE REGULARLY HAVE DIFFICULTY IN DRESSING 
APPROPRIATELY? 
For example does he or she have difficulty in buttoning her shirt /blouse or in wearing 
his dhoti/saree? 
                                                                  (i) YES      (ii) NO 
6) DOES HE/SHE URINATE IN AN APPROPRIATE PLACE? 
                                                                    (i) YES      (ii) NO  
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7) DOES HE/SHE HAVE DIFFICULTY RECOGNISING FAMILIAR FACES? 
 For example does he/she recognize close relatives? 
                                                                    (i) YES      (ii) NO 
8) DOES HE OR SHE HAVE DIFFICULTY RECOGNISING FAMILIAR 
OBJECTS? 
FOR EXAMPLE DOES HE/SHE RECOGNISE COMMON OBJECTS LIKE KEYS, 
COMB, and SPOONS etc.? 
                                                                    (i) YES      (ii) NO 
9) IS HE/SHE ABLE TO GO THE MARKET AND PURCHASE THINGS LIKE 
BEFORE? 
                                                                     (i) YES      (ii) NO 
10) HAS HE/SHE EVER GOT LOST IN THE VILLAGE/TOWN? 
                                                                     (i) YES      (ii) NO 
11) HAS THERE BEEN A WORSENING OF HIS/HER PROBLEMS IN THE 
LAST 1-YEAR OR SO?  
                                                                   (i) YES      (ii) NO 
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khjphp   Njh;T 
 
Njh;thsh; : ehd; ,g;nghOJ cq;fsplk; rpy Nfs;tpfis Nfl;Ngd; ePq;fs; jahwh? 
 
 
khjphp   Njh;T 1) 
khjphp   Njh;T 2) 
khjphp   Njh;T 3) 
 
1. ehd; nrd;idf;F nrd;W  %d;W nghUl;fis nfhz;L te;Njd;.  mit  khk;gok; , 
ehw;fhyp kw;Wk; xU ehzak; MFk;. ehd; nfhz;L te;j %d;W  nghUl;fs; 
vd;dntd;W cq;fshy; nrhy;y KbTkh.? 
 
 ehd; nrd;idapypUe;J nfhz;L te;j %d;W nghUl;fspd; ngah;fis  epidtpy; 
itj;Jf;nfhs;Sq;fs;, Vnddpy; mtw;iw rpwpJ Neuk; fopj;J  cq;fis ehd; epidTgLj;j 
nrhy;Ntd;. 
 
2. vdJ Kfj;ij ghh;j;J ehd; nra;tij mg;gbNa jpUg;gpr;nra;aTk (cq;fs; 
 fz;;;;;;;fis ,uz;L tpehbfs; %bitj;J , gpwF jpwf;fTk;). 
 
3. cq;fsJ tPl;ilg;gw;wp  xU thf;fpak; $wTk;. 
 
4. xU nkOFth;j;jpia vg;gb nfhSj;JtJ vd nra;J fhl;lTk;. 
 
5. cq;fsJ jiy Kbia vg;gb rPTtJ vd nra;Jf; fhl;lTk;. 
 
6. ,J vd;d? (xU rhtpia fhl;lTk;). 
 
7. cq;fsJ fz;fis %bf;nfhz;L cq;fs; ifapy; vd;d ,Uf;fpwJ vd  vd;dplk; $wTk;. 
 (xU rPg;ig NehAw;wtupd; ifapy; itf;fTk;). 
 
8. ,e;j fhfpj;ij cq;fs; tyJ ifapy; vLj;J, ,uz;lhf kbj;J, cq;fs; ,lJ  Gwk; itf;fTk;. 
 
9. cq;fshy; ,e;j G+l;il jpwf;f KbAkh?. 
 






1. mth; rkPgj;jpy; ele;j  tp\aq;fis tof;fkhf kwe;J tpLfpwhuh? 
 
 Cjhuzkhf mth; mg;nghOJ jhd; rhg;gpl;ij kwe;J tpl;L kPz;Lk; czT  
 Nfl;fpwhuh? 
 
2. mth; jdJ clikfis vq;F itj;Njhk; vd Qhgfk;  nfhs;s  f\;lg;gLfpwhuh? 
  
 Cjhuzkhf mth; vq;F gzk; itj;Njhk; vd;gij tof;fkhf kwe;J  tpLfpwhuh? 
 m).  Mkhk;  M). ,y;iy. 
 96
 
3. mth; ciuahLk;NghJ rhpahd thh;j;ijfis fz;Lgpbf;f rpukg;gLfpwhuh 
 my;yJ jtwhd thh;j;ijfis mbf;;;;;;;;;;fb gad;gLj;Jfpwhuh? 
 
 1). Mkhk;  2). ,y;iy 
 
4. mth; tof;fkhf mthplk; nrhy;yg;gLk; tp\aq;fis Ghpe;Jf; nfhs;s 
 f\;lg;gLfpwhuh? 
 
 Cjhuzkhf, mtuhy; topKiwfisAk; ciuahly;fisAk; Ghpe;J nfhs;s  Kbfpwjh? 
 
 1). Mkhk;  2). ,y;iy 
 
5. mth; tof;fkhf rhpahf  cilazpa f\;lg; gLfpwhuh? 
 
 Cjhuzkhf mth; jdJ rl;il my;yJ ,utpf;if nghj;jhd; mzpaNth  my;yJ Ntl;b 
kw;Wk; Nriy cLj;jNth  f\;lg;gLfpwhuh? 
 
 1). Mkhk;  2). ,y;iy 
 
6. mth; rhpahd ,lj;jpy; rpWePh; fopf;fpwhuh? 
 1). Mkhk;  2). ,y;iy 
 
7. mth; gof;fkhd Kfq;fis milahsq;fhz f\;lg;gLfpwhuh? 
  
cjhuzkhf, mth; neUq;fpa cwtpdh;fis milahsq; fz;L nfhs;fpwhuh? 
 1). Mkhk;  2). ,y;iy  
 
8. mth; gof;fkhd nghUl;fis milahsq; fz;L nfhs;s f\;;lg;gLfpwhuh? 
 
cjhuzkhf, rhtp, rPg;G, fuz;b, Nghd;w nghJthd nghUl;fis milahsk;  fz;L 
nfhs;fpwhuh? 
 
 1) Mkhk;  2). ,y;iy 
 
9. mth; Kd;G Nghy re;ijf;Fr; nrd;W nghUl;fis thq;f Kbfpwhjh? 
  
 1). Mkhk;  2). ,y;iy 
 
10. mth; cq;fs; fpuhkj;jpy; my;yJ efuj;jpy; vg;NghNjDk; top jtwpg; NghdJ 
 cz;lh? 
 
 1). Mkhk;  2). ,y;iy 
 
 
11. Rkhuhf fle;j xU tUlj;jpy;  mtuJ gpur;rpidfs; NkhrkhdJ cz;lh? 
 
 1). Mkhk;  2). ,y;iy.  
  
 
